Pramod Malik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Pramod Malik has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Adam Slivka
2 shared publicationsEvan L. Fogel
2 shared publicationsGlen A. Lehman
2 shared publicationsJames L. Watkins
2 shared publicationsJeffrey Marks
2 shared publicationsJohn Goff
2 shared publications
Latest Publications
- 6 January 2016
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 128 (2) , 268-72
A novel multitarget stool DNA test for colorectal cancer screening.
Review of: Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014;370(14):1287–97. This Practice Pearl reviews the results of a prospective, multicenter, cross-sectional clinical study that evaluated the performance of a new multitarget stool DNA (or mt-sDNA) screening test for colorectal cancer (CRC) and compared it with a fecal immunochemical test (FIT) in individuals at average risk for CRC. The potential impact of this test on the future of CRC screening is also discussed in a brief commentary. mt-sDNA testing is a noninvasive screening test designed to detect DNA biomarkers associated with colorectal neoplasia and occult hemoglobin in the stool. The sensitivity of mt-sDNA testing for detection of CRC was 92.3%, compared with 73.8% for FIT (p = 0.002). Sensitivity for detecting advanced precancerous lesions was 42.4% for mt-sDNA testing and 23.8% for FIT (p < 0.001). The specificities of mt-sDNA testing and FIT were 86.6% and 94.9%, respectively (p < 0.001). mt-sDNA testing thus may be a first-line screening option for asymptomatic individuals at average risk for CRC who do not want to have a colonoscopy.
- 6 January 2016
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 128 (2) , 268-72
A novel multitarget stool DNA test for colorectal cancer screening.
Review of: Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014;370(14):1287–97. This Practice Pearl reviews the results of a prospective, multicenter, cross-sectional clinical study that evaluated the performance of a new multitarget stool DNA (or mt-sDNA) screening test for colorectal cancer (CRC) and compared it with a fecal immunochemical test (FIT) in individuals at average risk for CRC. The potential impact of this test on the future of CRC screening is also discussed in a brief commentary. mt-sDNA testing is a noninvasive screening test designed to detect DNA biomarkers associated with colorectal neoplasia and occult hemoglobin in the stool. The sensitivity of mt-sDNA testing for detection of CRC was 92.3%, compared with 73.8% for FIT (p = 0.002). Sensitivity for detecting advanced precancerous lesions was 42.4% for mt-sDNA testing and 23.8% for FIT (p < 0.001). The specificities of mt-sDNA testing and FIT were 86.6% and 94.9%, respectively (p < 0.001). mt-sDNA testing thus may be a first-line screening option for asymptomatic individuals at average risk for CRC who do not want to have a colonoscopy.
- 1 May 2015
- Published by Elsevier in Gastroenterology
- Vol. 148 (5) , 948-957.e2
Accuracy of Capsule Colonoscopy in Detecting Colorectal Polyps in a Screening Population
- 1 May 2015
- Published by Elsevier in Gastroenterology
- Vol. 148 (5) , 948-957.e2
Accuracy of Capsule Colonoscopy in Detecting Colorectal Polyps in a Screening Population
- 19 August 2008
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 54 (4) , 833-841
Randomized Study Comparing Two Regimens of Oral Sodium Phosphates Solution Versus Low-Dose Polyethylene Glycol and Bisacodyl
Purpose Low-volume bowel preparation regimens for colonoscopy are reported to improve patient acceptance and compliance. We sought to compare the bowel cleansing efficacy, tolerability, and acceptability of three low-volume regimens: an oral sodium phosphates solution 45/45 ml (NaP-45/45), a reduced-dose oral sodium phosphates solution 45/30 ml (NaP-45/30), and polyethylene glycol plus bisacodyl (PEG-2L). Results A total of 121 patients were evaluated (mean age 55.2 ± 8.9 years). Bowel cleansings rated as excellent and good were significantly different among the groups: NaP-45/45 = 98%, NaP-45/30 = 88%, and PEG-2L = 76% (P < 0.04). Side effects were not significantly different except for greater thirst in the NaP-45/45 group (P = 0.001) and increased vomiting in females using PEG-2L (two-tailed interaction, P < 0.10). Willingness to retake the preparation was higher among the sodium phosphates regimens (88, 95, and 73%, respectively; P = 0.019). Conclusions Better cleansing and willingness to retake the regimen was achieved with the oral sodium phosphates solutions than with polyethylene glycol plus bisacodyl.
- 19 August 2008
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 54 (4) , 833-841
Randomized Study Comparing Two Regimens of Oral Sodium Phosphates Solution Versus Low-Dose Polyethylene Glycol and Bisacodyl
Purpose Low-volume bowel preparation regimens for colonoscopy are reported to improve patient acceptance and compliance. We sought to compare the bowel cleansing efficacy, tolerability, and acceptability of three low-volume regimens: an oral sodium phosphates solution 45/45 ml (NaP-45/45), a reduced-dose oral sodium phosphates solution 45/30 ml (NaP-45/30), and polyethylene glycol plus bisacodyl (PEG-2L). Results A total of 121 patients were evaluated (mean age 55.2 ± 8.9 years). Bowel cleansings rated as excellent and good were significantly different among the groups: NaP-45/45 = 98%, NaP-45/30 = 88%, and PEG-2L = 76% (P < 0.04). Side effects were not significantly different except for greater thirst in the NaP-45/45 group (P = 0.001) and increased vomiting in females using PEG-2L (two-tailed interaction, P < 0.10). Willingness to retake the preparation was higher among the sodium phosphates regimens (88, 95, and 73%, respectively; P = 0.019). Conclusions Better cleansing and willingness to retake the regimen was achieved with the oral sodium phosphates solutions than with polyethylene glycol plus bisacodyl.
- 1 August 2005
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 62 (2) , 245-250
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis
- 1 August 2005
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 62 (2) , 245-250
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis
- 1 April 2005
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 61 (5) , AB100
Does Prophylactic Allopurinol Administration Reduce the Risk and Severity of Post-ERCP Pancreatitis: Randomized Prospective Multicenter Study
- 1 April 2005
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 61 (5) , AB100
Does Prophylactic Allopurinol Administration Reduce the Risk and Severity of Post-ERCP Pancreatitis: Randomized Prospective Multicenter Study
- 30 September 2004
- Published by Elsevier in Clinical Therapeutics
- Vol. 26 (9) , 1479-1491
Open-label, dose-ranging pilot study of 4 weeks of low-dose therapy with sodium phosphate tablets in chronically constipated adults
- 30 September 2004
- Published by Elsevier in Clinical Therapeutics
- Vol. 26 (9) , 1479-1491
Open-label, dose-ranging pilot study of 4 weeks of low-dose therapy with sodium phosphate tablets in chronically constipated adults
- 1 September 2003
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 98, S301-S302
MULTICENTER ENDOSCOPIST-BLINDED TRIAL OF LOW-DOSE BOWEL PREPARATIONS FOR COLONOSCOPY: LIQUID SODIUM PHOSPHATE VS. TWO DOSING REGIMENS OF TABLET SODIUM PHOSPHATE
An abstract is unavailable. This article is available as a PDF only.
- 1 September 2003
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 98, S301-S302
MULTICENTER ENDOSCOPIST-BLINDED TRIAL OF LOW-DOSE BOWEL PREPARATIONS FOR COLONOSCOPY: LIQUID SODIUM PHOSPHATE VS. TWO DOSING REGIMENS OF TABLET SODIUM PHOSPHATE
An abstract is unavailable. This article is available as a PDF only.
- 11 February 2003
- Vol. 87 (4) , 201-4
Spur cell anemia in alcoholic cirrhosis: cure by orthotopic liver transplantation and recurrence after liver graft failure.
Spur cell anemia is an acquired form of hemolytic anemia caused by a structural abnormality of red cell membranes that results in spiculated erythrocytes. These peculiarly shaped red blood cells, called acanthocytes, have a shortened survival and undergo splenic sequestration and destruction. Spur cell anemia has been known to occur in several conditions, including chronic liver disease, and more specifically in alcoholic cirrhosis. Treatment of this disorder has been disappointing and usually indicates end-stage liver disease. Liver transplantation has been reported as the most effective treatment. We herein present a case of severe spur cell hemolytic anemia that successfully reverted after orthotopic liver transplantation and recurred secondary to resumption of alcohol intake and consequent liver graft failure. This case conclusively demonstrates the association among alcoholic cirrhosis, end-stage liver disease, and spur cell hemolytic anemia.
- 11 February 2003
- Vol. 87 (4) , 201-4
Spur cell anemia in alcoholic cirrhosis: cure by orthotopic liver transplantation and recurrence after liver graft failure.
Spur cell anemia is an acquired form of hemolytic anemia caused by a structural abnormality of red cell membranes that results in spiculated erythrocytes. These peculiarly shaped red blood cells, called acanthocytes, have a shortened survival and undergo splenic sequestration and destruction. Spur cell anemia has been known to occur in several conditions, including chronic liver disease, and more specifically in alcoholic cirrhosis. Treatment of this disorder has been disappointing and usually indicates end-stage liver disease. Liver transplantation has been reported as the most effective treatment. We herein present a case of severe spur cell hemolytic anemia that successfully reverted after orthotopic liver transplantation and recurred secondary to resumption of alcohol intake and consequent liver graft failure. This case conclusively demonstrates the association among alcoholic cirrhosis, end-stage liver disease, and spur cell hemolytic anemia.
- 1 March 2001
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1511 (1) , 17-27
Human intestinal anion exchanger isoforms: expression, distribution, and membrane localization
- 1 March 2001
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1511 (1) , 17-27
Human intestinal anion exchanger isoforms: expression, distribution, and membrane localization
- 1 June 1999
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 49 (6) , 791-793
Chronic pancreatitis resulting from primary hydatid disease of the pancreas: a case report and review of the literature.
- 1 June 1999
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 49 (6) , 791-793
Chronic pancreatitis resulting from primary hydatid disease of the pancreas: a case report and review of the literature.